Chemotherapy-Induced Peripheral Neuropathy in Head and Neck Cancer

Chemotherapy-Induced Peripheral Neuropathy in Head and Neck Cancer. Chemotherapy-induced peripheral neuropathy (CIPN) is a common side effect of head and neck cancer treatment. Learn symptoms, causes, and evidence-based integrative therapies to reduce nerve damage and improve quality of life.

While I have written many posts about CIPN and my cancer over the years, this post is directed specifically at head and neck cancer patients and survivors who experience chemotherapy-induced peripheral neuropathy. I do 4 of the 5 integrative therapies listed below.

I’ve linked the video below for two reasons. First, the speaker talks about the prevention of CIPN. Secondly, the oncologist admits that there are few, if any, effective treatments for CIPN. Meaning, few FDA-approved treatments that your oncologist can prescribe. Exercise, supplements, etc., are not FDA-approved conventional therapies.

If your CIPN resolves once treatment ends, great. Consider yourself lucky. However, if your CIPN continues, then this post is for you.

My recommendation is to undergo therapies to reduce or eliminate CIPN as soon as possible. Meaning, eat nutritiously, supplement (see below), exercise daily, undergo cryotherapy, and begin HBOT treatments as soon as possible.

You might find my other recommendation to be frustrating. And that is to prepare your body to withstand the toxicity of conventional treatments as best you can. Research shows that the therapies below can reduce or even eliminate side effects.

Be sure to watch each of the videos about:

Scroll down the page and post questions or comments. Hang in there, Be sure to read the study at the very end of this post.

Good luck,

David Emerson

Treatment strategies for chemotherapy-induced peripheral neuropathy

What is chemotherapy-induced peripheral neuropathy (CIPN)?

Chemotherapy-induced peripheral neuropathy (CIPN) is nerve damage caused by certain chemotherapy drugs. It leads to symptoms such as numbness, tingling, pain, and weakness—most commonly in the hands and feet—and can persist long after treatment ends.

What Is CIPN in Head and Neck Cancer?

Head and neck cancers are often treated with platinum-based chemotherapy (e.g., cisplatin) and taxanes—two of the most neurotoxic drug classes.

These therapies can damage peripheral nerves, leading to:

Tingling or “pins and needles”
Burning or shooting pain
Numbness in hands/feet
Loss of balance or coordination
Difficulty with fine motor skills (buttoning, writing)

CIPN is not rare—it is one of the most common dose-limiting side effects of chemotherapy.

Up to 68% of patients experience neuropathy within the first month after chemotherapy
Between 30–40% of patients develop persistent neuropathy
Prevalence across studies ranges from 19% to over 85%, depending on treatment type

Why Head and Neck Cancer Patients Are at Risk

While CIPN can occur in many cancers, head and neck cancer patients face specific risks due to treatment patterns:

1. Platinum-Based Chemotherapy (Cisplatin)

Common in head and neck cancer protocols
Highly neurotoxic
Causes cumulative nerve damage

2. Combination Therapy

Chemotherapy + radiation increases the overall toxicity burden

3. Treatment Intensity

Advanced-stage disease often requires aggressive, multi-cycle chemotherapy

4. Pre-existing Conditions

Diabetes, alcohol use, or nutritional deficiencies increase risk

How CIPN Develops

Chemotherapy drugs damage peripheral nerves through several mechanisms:

DNA damage to nerve cells
Oxidative stress and mitochondrial dysfunction
Disruption of microtubules (nerve transport systems)
Inflammation of nerve tissue

These effects primarily impact long nerves, which is why symptoms begin in the hands and feet.

How Long Does CIPN Last?

CIPN can be temporary or permanent.

Symptoms often begin during treatment or shortly after
About 30% of patients still have neuropathy 1 year later
Some survivors experience long-term or lifelong symptoms

Why CIPN Matters

CIPN is more than discomfort—it can affect survival and quality of life:

Leads to dose reductions or stopping chemotherapy early
Impairs daily functioning (walking, driving, writing)
Increases risk of falls and injury
Reduces long-term quality of life

Evidence-Based Conventional Treatments

There is no FDA-approved cure for CIPN, but some therapies help manage symptoms:

Medications

Duloxetine (best-supported option)
Gabapentin or pregabalin (limited evidence)

Physical Therapy

Improves balance and strength
Reduces fall risk

Dose Modification

Reducing or stopping neurotoxic drugs when symptoms worsen

Integrative Therapies for CIPN (Evidence-Based)

PeopleBeatingCancer focuses on non-toxic, evidence-based therapies that may reduce symptoms and support nerve repair.

1. Exercise (Strong Evidence)

Improves circulation and nerve function
Reduces the severity of symptoms

Research shows exercise can decrease neuropathy intensity and improve balance

2. Acupuncture

May reduce pain and improve nerve signaling
Increasing evidence in cancer populations

3. Nutritional Support

Key nutrients:

Vitamin B-complex (especially B12)
Omega-3 fatty acids
Alpha-lipoic acid (ALA)

⚠️ Note: Some supplements (e.g., acetyl-L-carnitine) are not recommended based on clinical guidelines

4. Cryotherapy (Cold Therapy)

Cooling hands/feet during infusion
May reduce drug delivery to peripheral nerves

5. Mind-Body Therapies

Meditation, yoga, and stress reduction
Help manage chronic pain perception

Lifestyle Strategies to Reduce Risk

Patients can take proactive steps:

Maintain optimal blood sugar control
Address vitamin deficiencies
Limit alcohol intake
Stay physically active
Report symptoms early to oncologists

Key Takeaways

CIPN is common in head and neck cancer, especially with cisplatin-based therapy
Symptoms can be long-lasting or permanent
There is no cure, but many therapies can reduce the severity
Exercise and integrative approaches offer meaningful benefits
Early detection and intervention are critical

To learn more about managing head and neck cancer-

Core Pages

Chemotherapy-induced peripheral neuropathy in cancer
managing-cancer-side-effects
integrative-oncology

Cancer-Specific Pages

Can chemotherapy-induced neuropathy be reversed?

Chemotherapy-induced peripheral neuropathy may improve after treatment, but in many patients it persists long-term. Early intervention with exercise, symptom management, and integrative therapies offers the best chance of reducing severity.

Evidence Appendix

Seretny et al. “Incidence, prevalence, and predictors of CIPN”
https://pubmed.ncbi.nlm.nih.gov/25261162/
Colvin. “Chemotherapy-induced peripheral neuropathy”
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6499732/
Reviews on CIPN prevalence and mechanisms
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11674975/

Final Thought

If you are undergoing treatment for head and neck cancer and experiencing numbness, tingling, or pain—don’t ignore it. CIPN is common, but it is also manageable with the right combination of conventional and integrative strategies.

Simultaneous hyperbaric oxygen therapy during systemic chemotherapy reverses chemotherapy-induced peripheral neuropathy by inhibiting TLR4 and TRPV1 activation in the central and peripheral nervous system

Results: The mechanical and thermal behavior tests revealed that HBOT intervention during PAC treatment led to the early alleviation of CIPN symptoms and inhibited CIPN deterioration. IF staining revealed that TLR4, TRPV1, and microglial activation were all upregulated in PAC-injected rats and exhibited early and significant downregulation in SHBOT-treated rats.

Conclusion: This study is the first to demonstrate that the use of SHBOT during PAC treatment has potential for the early suppression of CIPN initiation and deterioration, indicating that it can alleviate CIPN symptoms and may reverse CIPN in patients undergoing systemic chemotherapy…